... Over the past decades, it became clear that striatal projection neurons, the so-called medium spiny neurons (MSNs), undergo complex structural changes in the density, morphology and ultrastructural features of their dendritic spines in animal models of Parkinson's disease (PD) or after chronic exposure to cocaine or other psychostimulants (Table 1). In PD, nigrostriatal dopamine degeneration results in a significant loss of dendritic spines on MSNs of the dorsal striatum Ingham et al, 1989Ingham et al, , 1998Anglade et al., 1996;Stephens et al., 2005;Zaja-Milatovic et al., 2005;Day et al., 2006;Deutch et al., 2007;Villalba et al., 2009;Villalba and Smith, 2010), while rodents chronically treated with dopamine-enhancing drugs such as cocaine and other psychostimulants, display significant increases in spine density on MSNs in the nucleus accumbens (Robinson and Kolb, 1997, 2001, 2004Norrholm et al. 2003;Lee et al. 2006;Kalivas 2007a,b;Russo et al., 2009;Shen et al., 2009). Together, these data strongly suggest that the opposite changes in striatal dopamine (DA) release in these disorders may play a major role in mediating differential effects towards spine development, pruning and morphogenesis in striatal projection neurons in PD and addiction to psychostimulants (Arbuthnot et al., 1998;Robinson and Kolb, 1999a;Day et al., 2006;Deutch et al., 2007;Surmeier et al., 2007;Villalba et al., 2009;Garcia et al., 2010;Fasano et al., 2013) (Fig. 1). ...